The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder

BMC Psychiatry

Volumn 10, Issue , 2010, Pages

  Lonsdorf, Tina B ^a,c,d,f   Rück, Christian ^b   Bergström, Jan ^b   Andersson, Gerhard ^b,e   Öhman, Arne ^a,c,d   Lindefors, Nils ^b   Schalling, Martin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Stockholm Brain Institute   (Sweden)

^d Nordic center of Excellence in Cognitive Control   (Sweden)

^e LINKÖPING UNIVERSITY   (Sweden)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CATECHOL METHYLTRANSFERASE; METHIONINE; SEROTONIN UPTAKE INHIBITOR; VALINE; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; COGNITIVE THERAPY; EXPOSURE; FEAR; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PSYCHOEDUCATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM; TREATMENT OUTCOME; BEHAVIOR THERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETICS; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; REINFORCEMENT;

ADULT; CATECHOL O-METHYLTRANSFERASE; COGNITIVE THERAPY; EXTINCTION, PSYCHOLOGICAL; FEAR; FEMALE; GENOTYPE; HUMANS; IMPLOSIVE THERAPY; MALE; METHIONINE; MIDDLE AGED; PANIC DISORDER; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TREATMENT OUTCOME; VALINE;

EID: 78649319506     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-10-99     Document Type: Article

References (39)

1. Linden DEJ. How psychotherapy changes the brain - the contribution of functional neuroimaging. Molecular Psychiatry 2006, 11:528-538. 10.1038/sj.mp.4001816, 16520823.
2. Kandel ER. Biology and the future of psychoanalysis: A new intellectual framework for psychiatry revisited. American Journal of Psychiatry 1999, 156:505-524.
3. Lonsdorf TB, Weike AI, Nikamo P, Schalling M, Hamm AO, Ohman A. Genetic Gating of Human Fear Learning and Extinction: Possible Implications for Gene-Environment Interaction in Anxiety Disorder. Psychological Science 2009, 20:198-206. 10.1111/j.1467-9280.2009.02280.x, 19175757.
4. Weinshilboum RM, Otterness DM, Szumlanski CL. Methylation pharmacogenetics: Catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annual Review of Pharmacology and Toxicology 1999, 39:19-52. 10.1146/annurev.pharmtox.39.1.19, 10331075.
5. Chen JS, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, et al. Functional analysis of genetic variation in catechol-o-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004, 75:807-821. 10.1086/425589, 1182110, 15457404.
6. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6:243-250. 10.1097/00008571-199606000-00007, 8807664.
7. Kolassa IT, Kolassa S, Ertl V, Papassotiropoulos A, De Quervain DJF. The Risk of Posttraumatic Stress Disorder After Trauma Depends on Traumatic Load and the Catechol-O-Methyltransferase Val(158)Met Polymorphism. Biological Psychiatry 67:304-308. 10.1016/j.biopsych.2009.10.009, 19944409.
8. Heinz A, Smolka MN. The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Reviews in the Neurosciences 2006, 17:359-367.
9. Bilder RM, Volavka J, Lachman HM, Grace AA. The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 2004, 29:1943-1961. 10.1038/sj.npp.1300542, 15305167.
10. Domschke K, Freitag CM, Kuhlenbaumer G, Schirmacher A, Sand P, Nyhuis P, Jacob C, Fritze J, Franke P, Rietschel M, et al. Association of the functional V158 M catechol-O-methyl-transferase polymorphism with panic disorder in women. International Journal of Neuropsychopharmacology 2004, 7:183-188. 10.1017/S146114570400416X, 15009906.
11. Rothe C, Koszycki D, Bradwejn J, King N, Deluca V, Tharmalingam S, Macciardi F, Deckert J, Kennedy JL. Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology 2006, 31:2237-2242.
12. Domschke K, Deckert J, O'Donovan MC, Glatt SJ. Meta-analysis of COMT val158met in panic disorder: Ethnic heterogeneity and gender specificity. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 2007, 144B:667-673.
13. Bergstrom J, Andersson G, Ljotsson B, Ruck C, Andreewitch S, Karlsson A, Carlbring P, Andersson E, Lindefors N. Internet-versus group-administered cognitive behaviour therapy for panic disorder in a psychiatric setting: a randomised trial. Bmc Psychiatry 2010, 10. 10.1186/1471-244X-10-54, 2910662, 20598127.
14. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl 20):22-33. quiz 34-57.
15. Zigmond AS, Snaith RP. THE HOSPITAL ANXIETY AND DEPRESSION SCALE. Acta Psychiatrica Scandinavica 1983, 67:361-370. 10.1111/j.1600-0447.1983.tb09716.x, 6880820.
16. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale - An updated literature review. Journal of Psychosomatic Research 2002, 52:69-77. 10.1016/S0022-3999(01)00296-3, 11832252.
17. Bergstrom J, Andersson G, Karlsson A, Andreewitch S, Ruck C, Carlbring P, Lindefors N. An open study of the effectiveness of Internet treatment for panic disorder delivered in a psychiatric setting. Nordic Journal of Psychiatry 2009, 63:44-50. 10.1080/08039480802191132, 18985514.
18. Geijer T, Neiman J, Rydberg U, Gyllander A, Jonsson E, Sedvall G, Valverius P, Terenius L. DOPAMINE D2-RECEPTOR GENE POLYMORPHISMS IN SCANDINAVIAN CHRONIC-ALCOHOLICS. European Archives of Psychiatry and Clinical Neuroscience 1994, 244:26-32. 10.1007/BF02279808, 7918698.
19. Livak KJ. Allelic discrimination using fluorogenic probes and the 5 ' nuclease assay. Genetic Analysis-Biomolecular Engineering 1999, 14:143-149. 10.1016/S1050-3862(98)00019-9, 10084106.
20. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D. Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatric Genetics 2003, 13:33-41. 10.1097/00041444-200303000-00006, 12605099.
21. Bouton ME, Mineka S, Barlow DH. A modern learning theory perspective on the etiology of panic disorder. Psychological Review 2001, 108:4-32. 10.1037/0033-295X.108.1.4, 11212632.
22. Myers KM, Davis M. Mechanisms of fear extinction. Molecular Psychiatry 2007, 12:120-150. 10.1038/sj.mp.4001939, 17160066.
23. Kim W, Choi YH, Yoon KS, Cho DY, Pae CU, Woo JM. Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2006, 30:1413-1418.
24. Roffman JL, Marci CD, Glick DM, Dougherty DD, Rauch SL. Neuroimaging and the functional neuroanatomy of psychotherapy. Psychological Medicine 2005, 35:1385-1398. 10.1017/S0033291705005064, 16164763.
25. Bryant RA, Felmingham KL, Falconer EM, Benito LP, Dobson-Stone C, Pierce KD, Schofield PR. Preliminary Evidence of the Short Allele of the Serotonin Transporter Gene Predicting Poor Response to Cognitive Behavior Therapy in Posttraumatic Stress Disorder. Biological Psychiatry 2010, 67:1217-1219. 10.1016/j.biopsych.2010.03.016, 20434135.
26. Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. American Journal of Psychiatry 2000, 157:493-505. 10.1176/appi.ajp.157.4.493, 10739407.
27. Kiropoulos LA, Klein B, Austin DW, Gilson K, Pier C, Mitchell J, Ciechomski L. Is internet-based CBT for panic disorder and agoraphobia as effective as face-to-face CBT?. Journal of Anxiety Disorders 2008, 22:1273-1284. 10.1016/j.janxdis.2008.01.008, 18289829.
28. Carlbring P, Nilsson-Ihrfelt E, Waara J, Kollenstam C, Buhrman M, Kaldo V, Soderberg M, Ekselius L, Andersson G. Treatment of panic disorder: live therapy vs. self-help via the Internet. Behaviour Research and Therapy 2005, 43:1321-1333. 10.1016/j.brat.2004.10.002, 16086983.
29. Reger MA, Gahm GA. A Meta-Analysis of the Effects of Internet- and Computer-Based Cognitive-Behavioral Treatments for Anxiety. Journal of Clinical Psychology 2009, 65:53-75. 10.1002/jclp.20536, 19051274.
30. Anttila S, Huuhka K, Huuhka M, Illi A, Rontu R, Leinonen E, Lehtimaki T. Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy. Pharmacogenomics Journal 2008, 8:113-116. 10.1038/sj.tpj.6500468, 17700596.
31. Domschke K, Zavorotnyy M, Diemer J, Nitsche S, Hohoff C, Baune BT, Deckert J, Arolt V, Zwanzger P. COMT val158met Influence on Electroconvulsive Therapy Response in Major Depression. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 2010, 153B:286-290.
32. Huuhka K, Anttila S, Huuhka M, Hietala J, Huhtala H, Mononen N, Lehtimaki T, Leinonen E. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy. Neuroscience Letters 2008, 448:79-83. 10.1016/j.neulet.2008.10.015, 18929622.
33. Szegedi A, Rujescu D, Tadic A, Muller MJ, Kohnen R, Stassen HH, Dahmen N. The catechol-O-methyltransferase Val(108/158)Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. Pharmacogenomics Journal 2005, 5:49-53. 10.1038/sj.tpj.6500289, 15520843.
34. Arias B, Serretti A, Lorenzi C, Gasto C, Catalan R, Fananas L. Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. Journal of Affective Disorders 2006, 90:251-256. 10.1016/j.jad.2005.11.008, 16356553.
35. Baune BT, Hohoff C, Berger K, Neumann A, Mortensen S, Roehrs T, Deckert J, Arolt V, Domschke K. Association of the COMT val158met variant with antidepressant treatment response in major depression. Neuropsychopharmacology 2008, 33:924-932. 10.1038/sj.npp.1301462, 17522626.
36. Inada T, Nakamura A, Iijima Y. Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 2003, 120B:35-39.
37. Bryant RA, Felmingham KL, Falconer EM, Pe Benito L, Dobson-Stone C, Pierce KD, Schofield PR. Preliminary Evidence of the Short Allele of the Serotonin Transporter Gene Predicting Poor Response to Cognitive Behavior Therapy in Posttraumatic Stress Disorder. Biological Psychiatry Corrected Proof.
38. Hofmann SG, Pollack MH, Otto MW. Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. Cns Drug Reviews 2006, 12:208-217. 10.1111/j.1527-3458.2006.00208.x, 2151200, 17227287.
39. Kandel ER. A new intellectual framework for psychiatry. American Journal of Psychiatry 1998, 155:457-469.